on Evotec AG (NASDAQ:EVTCY)
Evotec SE Set to Announce 2023 Fiscal Year Results
Hamburg-based Evotec SE will release its financial results for the year 2023 on April 24, 2024. Recognized on the Frankfurt Stock Exchange with symbols EVT, MDAX, TecDAX, and on NASDAQ as EVO, the life science company continues to engage its stakeholders effectively. A conference call, conducted in English, is scheduled to discuss the details and updates of the company's performance.
The announcement outlined webcast and conference call details, indicating that those interested can participate directly or through a pre-register link provided for phone access. Presentation materials will be accessible during the call, ensuring participants can follow the proceedings comprehensively.
Evotec’s broad engagement is further exemplified by its collaborations across top pharmaceutical companies and various biotechnology firms. The company strategically positions itself in key therapeutic sectors like neurology, oncology, and infectious diseases, emphasizing its role in innovative healthcare solutions.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news